Connect with us

Technology

A new way to beat jet lag? Engineered cells speed circadian adjustment

Published

on

Peer-reviewed publication highlights the use of encapsulated leptin-producing cells to accelerate circadian realignment in preclinical models

HOUSTON, Aug. 14, 2026 /PRNewswire/ — Adjusting to a new time zone or work schedule can leave the body’s internal clock out of sync for days, contributing to sleep disruption, metabolic changes and other health consequences. Researchers at Rice University, with the support of the Rice Biotech Launch Pad, and Northwestern University have developed an implantable cell therapy that may help the body adapt more quickly to these disruptions.

In a recent study titled “Encapsulated Leptin-Producing Cells Facilitate Entrainment of Circadian Rhythms in Rodents and Nonhuman Primates,” encapsulated cells engineered to continuously produce the metabolic hormone leptin reduced the time required for animals to adjust to shifts in the light-dark cycle that mimic jet lag and shift work. Published in Advanced Science, the study’s indings demonstrate a new approach to regulating circadian rhythms through metabolic signaling and provide early evidence that engineered cell therapies could be used to address circadian disruption.

“Current approaches for adjusting circadian rhythms rely heavily on precisely timed behaviors such as light exposure, meal schedules or melatonin administration,” said Omid Veiseh, professor of bioengineering at Rice and faculty director of the Rice Biotech Launch Pad. “We wanted to explore whether a temporary cell therapy could provide a more practical way to help the body adapt to changing schedules.”

The therapy consists of human retinal pigment epithelial cells engineered to produce leptin, a hormone best known for regulating appetite and metabolism. The cells are encapsulated within microscopic alginate spheres that protect them from the immune system while allowing therapeutic proteins to diffuse into the body. Following a simple subcutaneous injection, the encapsulated cells temporarily elevate circulating leptin levels before naturally losing viability over time.

“Metabolism and circadian rhythms are closely connected, but the therapeutic potential of that relationship remains largely unexplored,” said Martha Hotz Vitaterna, professor of neurobiology at Northwestern University and co-corresponding author on the study. “These findings suggest that metabolic signals can be leveraged to accelerate adaptation to circadian disruptions.”

In mouse studies, animals receiving the leptin-producing cell therapy adjusted significantly faster following both phase advances and phase delays in the light-dark cycle. Mice treated with the therapy adapted to a four-hour schedule delay 50% faster days than in control animals.

To evaluate the translational potential of the approach, the researchers tested the therapy in cynomolgus macaques, whose sleep-wake patterns more closely resemble those of humans. The treatment was well tolerated and reduced entrainment time following six-hour schedule shifts by approximately one day compared to controls.

“The fact that we observed similar effects in both rodents and non-human primates suggests that the underlying biology may be conserved across species,” said Fred Turek, director of Northwestern’s Center for Sleep and Circadian Biology and a senior author on the study.

Researchers monitored multiple physiological indicators of circadian alignment, including activity, heart rate and core body temperature. Across these measures, animals receiving the leptin-producing implants adapted more rapidly to the new schedules than untreated controls.

Importantly, the therapy did not negatively affect sleep. Analysis of sleep architecture in non-human primates showed no reduction in total sleep time, rapid eye movement sleep or non-REM sleep. Researchers also observed increases in slow-wave sleep activity following some schedule shifts, suggesting a potential improvement in sleep quality during recovery.

Beyond demonstrating efficacy, the study also evaluated the safety and practicality of the platform. Blood tests and clinical monitoring showed no signs of significant toxicity in non-human primates, and animals receiving multiple doses over the course of a year experienced no long-term adverse effects. The encapsulated cells remained active for several days before naturally declining, creating a temporary and reversible intervention.

“Our goal was not to permanently alter the circadian system,” Samantha Fleury, first author on the publication, said. “We wanted a therapy that could provide short-term support during periods of disruption and then naturally resolve.”

The researchers believe the platform could eventually be explored for applications involving frequent circadian disruption, including shift work, military operations, international travel and other situations where rapid adaptation to changing schedules is important. Ft

“This work provides further evidence that metabolic pathways can be harnessed to influence circadian biology,” said Jonathan Rivnay, professor of biomedical engineering and materials science and engineering at Northwestern University and a senior author on the study. “More broadly, it demonstrates how engineered cell therapies can be used to deliver biologically active molecules in ways that would be difficult to achieve through conventional dosing.”

The team plans to further investigate the mechanisms linking leptin and circadian regulation and explore next-generation versions of the platform capable of providing tunable or repeatable circadian support.

The research was supported by the 711th Human Performance Wing and the Defense Advanced Research Projects Agency under agreement number FA8650-21-1-7119.

This news release can be found online at news.rice.edu.

Follow Rice News and Media Relations via Twitter @RiceUNews.

Peer-reviewed paper:

Encapsulated Leptin-Producing Cells Facilitate Entrainment of Circadian Rhythms in Rodents and Nonhuman Primates | Advanced Science

Authors: Samantha T. Fleury, Xuanyi Lin, Peter D. Rios, Christopher Olker, Eun Joo Song, Alejandra Cobos Perez, Cody Fell, Daisy Lopez, Ira Joshi, Hafsa Nasir, Cecelia Curtis, Danna Muringi, Kaiyuan Wang, José Oberholzer, Fred W. Turek, Isaac B. Hilton, Jonathan Rivnay, Martha Hotz Vitaterna, Omid Veiseh

About Rice:

Located on a 300-acre forested campus in Houston, Texas, Rice University is consistently ranked among the nation’s top 20 universities by U.S. News & World Report. Rice has highly respected schools of architecture, business, continuing studies, engineering and computing, humanities and arts, music, natural sciences and social sciences and is home to the Baker Institute for Public Policy. Internationally, the university maintains the Rice Global Paris Center, a hub for innovative collaboration, research and inspired teaching located in the heart of Paris. With 4,776 undergraduates and 4,104 graduate students, Rice’s undergraduate student-to-faculty ratio is just under 6-to-1. Its residential college system builds close-knit communities and lifelong friendships, just one reason why Rice is ranked No. 1 for lots of race/class interaction and No. 7 for best-run colleges by the Princeton Review. Rice is also rated as a best value among private universities by the Wall Street Journal and is included on Forbes’ exclusive list of “New Ivies.”

If you do not wish to receive news releases from Rice University, reply to this email and write “unsubscribe” in the subject line. Rice University, Office of News and Media Relations–MS 300, 6100 Main St., Houston, TX 77005.

About the Rice Biotech Launch Pad:  

The Rice Biotech Launch Pad is a Houston-based accelerator focused on expediting the translation of Rice University’s health and medical technology discoveries into cures. This initiative is designed to help advance internally discovered platform technologies from concept to clinical studies and commercialization. The Rice Biotech Launch Pad will identify and support highly differentiated projects while driving the expansion of Houston as a world-class medical innovation ecosystem. The accelerator will bring together local researchers with a network of industry executives. For more information, please visit https://biotechlaunchpad.rice.edu/.

Media Contact:

Russo Partners
David Schull or Liz Phillips
(347) 956-7697
david.schull@russopartnersllc.com 
elizabeth.phillips@russopartnersllc.com

View original content:https://www.prnewswire.com/news-releases/a-new-way-to-beat-jet-lag-engineered-cells-speed-circadian-adjustment-302851453.html

SOURCE Rice University

Continue Reading

Technology

Atalanta CEO Anjana Rajan Addresses Software Understanding Gap at The National Academies Cyber Resilience Forum

Published

on

By

Rajan’s remarks come amid a string of major technology outages across critical infrastructure

WASHINGTON, Nov. 20, 2026 /PRNewswire/ — The National Academies of Sciences, Engineering, and Medicine’s Forum on Cyber Resilience concluded today after two days of sessions with leaders from the NSA, the Department of War, AWS, Google, Microsoft, and others on the technical and operational challenges of closing the software understanding gap.

The forum convened as outages across transportation, banking, telecommunications, and national security exposed vulnerabilities in the complex systems underpinning U.S. critical infrastructure. Because these systems are built, maintained, and operated by multiple stakeholders across domains, it is increasingly difficult to predict how they will behave when something goes wrong.

Anjana Rajan, CEO and Co-Founder of Atalanta, gave a presentation titled “Forward Deployed Formal Methods,” which discussed Atalanta’s learnings from the front lines on how to apply mathematical rigor to real world missions.

“Over the last week, we have seen elected officials and leaders not know what caused these outages,” said Rajan. “There is a name for this phenomenon, and it’s called the software understanding gap.”

During her remarks, Rajan announced the launch of Ata, Atalanta’s new formal verification language. Ata brings mathematical verification to the operators responsible for today’s critical systems so they can verify how those systems will behave under normal, abnormal, or hostile conditions.

“How do I know my critical infrastructure will perform as intended, even when under attack?” Rajan said. “This is the fundamental challenge facing mission owners who need to know that the systems they depend on will work. Atalanta is already meeting this moment. “

Atalanta is currently working across a range of critical infrastructure sectors, including defense, space, and energy. In August, Viasat announced that it had used Atalanta’s platform, Argo, to demonstrate improved resilience of satellite networks against modern warfare threats. Atalanta is also supporting the Department of Energy’s Genesis Mission through its partnership with Idaho National Laboratory, bringing formal verification techniques to the development of autonomous nuclear reactors.

Press Contact
press@atalanta.tech

View original content:https://www.prnewswire.com/news-releases/atalanta-ceo-anjana-rajan-addresses-software-understanding-gap-at-the-national-academies-cyber-resilience-forum-302947339.html

SOURCE Atalanta

Continue Reading

Technology

S&P Global to Present at UBS Global Technology and AI Conference on December 2, 2026

Published

on

By

Session will be Webcast

NEW YORK, Nov. 20, 2026 /PRNewswire/ — Martina Cheung, President and Chief Executive Officer of S&P Global (NYSE: SPGI), will participate in the UBS Global Technology and AI Conference on December 2, 2026 in Scottsdale, AZ. Ms. Cheung is scheduled to speak from 9:35 a.m. to 10:05 a.m. Mountain Standard Time (11:35 a.m. Eastern Standard Time). The “fireside chat” will be webcast and may include forward-looking information. Mark Grant, Senior Vice President of Investor Relations and Treasurer, will join for investor meetings.

Webcast Instructions:  Live and Replay
The webcast (audio-only) will be available live and in replay through the Company’s Investor Relations website http://investor.spglobal.com/Investor-Presentations. Any additional information presented during the session will be made available on the Company’s Investor Presentations web page.

About S&P Global
S&P Global (NYSE: SPGI) enables businesses, governments, and individuals with trusted data, expertise and technology to make decisions with conviction. We are Advancing Essential Intelligence through world-leading benchmarks, data, and insights that customers need in order to plan confidently, act decisively, and thrive in a rapidly changing global landscape.

From helping our customers assess new investments across the capital and commodities markets to navigating the energy expansion, acceleration of artificial intelligence, and evolution of public and private markets, we enable the world’s leading organizations to unlock opportunities, solve challenges, and plan for tomorrow – today. Learn more at www.spglobal.com. 

Investor Relations:  http://investor.spglobal.com 

Contacts:

Investor Relations
Mark Grant
Senior Vice President, Investor Relations and Treasurer
Tel: + 1 (347) 640-1521
mark.grant@spglobal.com

Media
Christina Twomey
Chief Communications Officer
Tel: +1 (646) 407-3001
christina.twomey@spglobal.com

View original content:https://www.prnewswire.com/news-releases/sp-global-to-present-at-ubs-global-technology-and-ai-conference-on-december-2-2026-302947340.html

SOURCE S&P Global

Continue Reading

Technology

APEC CEO Summit 2026 Concludes Successfully in Shenzhen

Published

on

By

SHENZHEN, China, Nov. 20, 2026 /CNW/ — The APEC CEO Summit 2026 concluded on November 18 at the Qianhai International Convention Center in Shenzhen. Hosted by the China Council for the Promotion of International Trade (CCPIT), the summit was held from November 17 to 18 as a supporting event of the 33rd APEC Economic Leaders’ Meeting. President Xi Jinping attended the opening ceremony and delivered a keynote speech. The summit drew more than 2,000 political and business leaders from all 21 APEC economies and 13 economies beyond APEC, including the United Kingdom, France, Germany and Switzerland.

Under the theme “To Prosper and Win the Future Together,” the summit featured the opening ceremony, speeches by leaders of APEC economies, a business dialogue, thematic discussions, the closing ceremony and the handover of the hosting role. Leaders of APEC economies including Australia; Canada; Chile; Hong Kong, China; the Republic of Korea; Malaysia; Mexico; Russia; Thailand and Vietnam attended the summit, delivering speeches or remarks or joining panel discussions. More than 40 heads of leading Chinese and foreign companies and major business associations exchanged views on the Asia-Pacific economic outlook and new opportunities for cooperation, connectivity, artificial intelligence, sustainable development, the Free Trade Area of the Asia-Pacific (FTAAP), the digital economy, development of the Guangdong-Hong Kong-Macao Greater Bay Area, and digital and green transformation.

Ren Hongbin, Chairman of the CCPIT and Chair of the APEC CEO Summit 2026, presided over the opening ceremony. At the closing ceremony, on behalf of the Asia-Pacific business community, he released The Shenzhen Initiative of the Asia-Pacific Economic Cooperation (APEC) CEO Summit 2026, calling for deepening an open regional economy, driving inclusive growth through technological innovation, strengthening regional connectivity, and working together to achieve shared prosperity. It is the first time in the summit’s 30-year history that outcomes have been issued in the form of an initiative.

At the handover ceremony, Ren Hongbin passed the hosting role for the next APEC CEO Summit to Nguyen Quang Vinh, Vice Chairman of the Vietnam Chamber of Commerce and Industry.

More information: https://www.apecceosummit2026.cn/en/apec2026/

View original content to download multimedia:https://www.prnewswire.com/news-releases/apec-ceo-summit-2026-concludes-successfully-in-shenzhen-302947355.html

SOURCE CCPIT

Continue Reading

Trending